Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female Chinese subjects aged 18-65 years (including 65) at screening.
Subjects meeting the ICD-10 (Classification of Mental and Behavioral Disorders) criteria for schizophrenia (F20.X).
Subjects who are in acute phase of schizophrenia and are appropriate to receive intramuscular medication for at least 3 days
You may not be if
History of clinically significant physical illness especially myocardial infarction, non compensatory heart failure etc.
Subjects receiving an investigational agent in the previous 3 months prior to screening.
Use of antipsychotic agents within 12 hours or parenteral benzodiazepines within 4 hours prior to randomization and during the study.
Clareo Health | A Randomized, Open-Label, Multi-Center Study To Evaluate The Efficacy And Safety Of Intramuscular Ziprasidone In Patients With Agitation
